Understanding how certain brain receptors can be modulated to treat neurological disorders
Structural Determinants of Allosteric Modulation of Brain GPCRs
This study is exploring how certain compounds can change the way brain receptors work, with the goal of finding better treatments for conditions like Alzheimer's and schizophrenia, so that therapies can be more personalized for each patient.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-10650803 on NIH RePORTER |
What this research studies
This research investigates the role of G-Protein Coupled Receptors (GPCRs) in the human brain, focusing on how different compounds can modulate these receptors to develop new treatments for neurological disorders like Alzheimer's disease and schizophrenia. The study aims to identify how structural changes in these compounds affect their interaction with various receptor subtypes, which can lead to different therapeutic outcomes. By examining the effects of over 10,000 identified compounds, the research seeks to understand the mechanisms behind positive and negative allosteric modulation of these receptors. This knowledge could pave the way for more effective treatments tailored to individual patient needs.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or other related neurological disorders.
Not a fit: Patients with neurological disorders not related to GPCR modulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to novel treatment strategies that improve outcomes for patients with Alzheimer's disease and other neurological disorders.
How similar studies have performed: Previous research has shown promise in targeting GPCRs for neurological disorders, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Meiler, Jens — Vanderbilt University
- Study coordinator: Meiler, Jens
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.